Ceplene Articles
Meda debuts leukemia drug Ceplene in the UK
20 January 2011
EpiCept shares hammered as FDA calls for additional study on AML drug candidate Ceplene
24 August 2010
Showing 1-5 of 5 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
